The colocalization of CTGF (green fluorescence) and DGC (red fluorescence) in the brain sections of AD patients was also observed, confirm the targeting specificity of DGC against CTGF in human brains (Fig. 7b). This evidence concerns the gene CCN2 and Alzheimer disease.